CD44 and breast carcinoma: Similarly, other conventional stem cell markers such as CD133-, CD44-, CD49f-, and ALDH-expressing stem cells regulate various signaling networks, including the Notch, Hedgehog, and Wnt pathways, for maintenance and proliferation in breast cancer.